Trump Delays AI Executive Order Citing Concerns Over Potential Regulatory Blockage Kazatomprom Reports 17 Production Surge in Third Quarter Potentially Impacting Uranium Supply Softcat Raises Annual Profit Outlook as AI Infrastructure Demand Surges Amid Chip Shortage Prairie Operating PROP Faces NearTerm Headwinds But Bullish Thesis Remains Intact PutinXi Talks Revive Stalled Power of Siberia 2 Pipeline Amid Iran War Disruptions Russia Warns US Citizens to Leave Kyiv as Moscow Announces Systematic Strikes on Ukrainian Capital THRM Q1 2026 Earnings Profit Surge Defies Estimates as Automotive Climate Control Demand Boosts Margins Beasley Broadcast Group Inc Q4 2025 Earnings Significant EPS Loss Amid Operational Headwinds AIT Q1 2026 Earnings Narrow Profit Miss Amidst Steady Operational Performance MHK Q1 2026 Earnings EPS Surprises on Cost Actions Shares Edge Higher WLFC Q1 2026 Earnings EPS Surges Past Estimates with 354 Beat PODD Q1 2026 Earnings EPS Surprises by 16 as Revenue Details Remain Withheld Cohen Steers ClosedEnd Opportunity Fund FOF Edges Higher Key Levels in Focus Sweetgreen Inc SG Slides 532 Key Support Levels in Focus After Sharp Pullback RingCentral RNG Holds Steady Near 4260 Amid Cautious Market Sentiment Extreme Networks EXTR Surges 7 on Strong Volume Approaches Resistance at 2688 Zimmer Biomet ZBH Holds Steady Near Support Modest Gains Amid Sector Pressure Nvidias Annual Spending on Taiwan AI Suppliers Could Reach 150 Billion Says Jensen Huang Warren Buffetts Tiny Purchase Hint in March May Be Confirmed by Latest Berkshire Filing Ebola Risk Escalation in DR Congo Potential Economic and Market Implications Morgan Stanley Adjusts Palo Alto Networks Price Target Amid Shifting Demand Trends Paul McCartneys Final Appearance Highlights CBSs Financial Decision to End Colberts Late Show BP Shares Dip as Board Removes Chairman Albert Manifold Over Conduct Concerns Perpetua Resources Secures 29 Billion US Loan for Idaho Gold and Antimony Project Red Violet Inc RDVT Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction Bolt Biotherapeutics BOLT Gains 36 as Biotech Sector Shows Renewed Interest